# STEM CELL THERAPEUTICS CORP: Form D filing

STEM CELL THERAPEUTICS CORP, a biotechnology company in Toronto, Ontario, Canada, filed a Form D with the SEC in 2013. The latest, on December 23, 2013, reports $30.3 million sold of a $60.7 million offering to 22 investors.

Find out what STEM CELL THERAPEUTICS CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20STEM%20CELL%20THERAPEUTICS%20CORP%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=STEM%20CELL%20THERAPEUTICS%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Fstem-cell-therapeutics-corp-1392333)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20STEM%20CELL%20THERAPEUTICS%20CORP%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=STEM%20CELL%20THERAPEUTICS%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Fstem-cell-therapeutics-corp-1392333)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 96 Skyway Avenue, Toronto, Ontario, Canada, M9W 4
- Phone: (416) 457-4670
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Ontario, Canada
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1392333

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 23, 2013 | New notice | $60,697,057 | $30,298,825 | $30,398,232 | 22 | Dec 13, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1392333/000114036113047323/0001140361-13-047323-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Robert Uger | Executive Officer |  |
| Niclas Stiernholm | Executive Officer, Director |  |
| Penka Petrova | Executive Officer |  |
| James Todd Parsons | Executive Officer |  |
| Ronald Dean Peterson | Director |  |
| Michael G. Moore | Director |  |
| Henry G. Friesen | Director |  |
| James Michael DeMesa | Director |  |
| David Geoffrey Peter Allan | Director |  |
| Calvin Ralph Stiller | Director |  |

[Every Form D from the week of Dec 23, 2013](https://specstream.ai/data/form-d/week/2013-12-23) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what STEM CELL THERAPEUTICS CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).